Quick Answer
AVITA Medical, Inc. reported Operating Income Loss of -$42.53 million for the year ending 2025.
- AVITA Medical, Inc. showed an increase of +24.8% in Operating Income Loss from 2024 to 2025.
- This data is from AVITA Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2018: -$5.06 million | Q4 2018: -$6.30 million | Q1 2019: -$6.68 million | Q2 2019: -$7.49 million | Q3 2019: -$3.66 million | Q4 2019: -$10.59 million | Q1 2020: -$15.41 million | Q2 2020: -$13.02 million | Q3 2020: -$10.21 million | Q4 2020: -$5.63 million | Q1 2021: -$5.99 million | Q2 2021: -$4.70 million | Q3 2021: -$5.95 million | Q1 2022: -$9.49 million | Q2 2022: -$6.36 million | Q3 2022: -$5.75 million | Q1 2023: -$9.91 million | Q2 2023: -$11.17 million | Q3 2023: -$9.31 million | Q1 2024: -$17.21 million | Q2 2024: -$15.62 million | Q3 2024: -$13.81 million | Q1 2025: -$11.83 million | Q2 2025: -$11.15 million | Q3 2025: -$9.15 million.
- Over the full 8 years of available data (2018 to 2025), AVITA Medical, Inc.'s Operating Income Loss has declined by 207.3%.
- Historical annual values: Fiscal year 2025: -$42.53 million | Fiscal year 2024: -$56.59 million | Fiscal year 2023: -$42.66 million | Fiscal year 2022: -$27.51 million | Fiscal year 2021: -$26.54 million | Fiscal year 2020: -$42.68 million | Fiscal year 2019: -$25.53 million | Fiscal year 2018: -$13.84 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: